Skip to content

Oaktree Specialty Lending OCSL Unrealized losses, net

Unrealized losses, net at other companies

Hercules Capital logo
Hercules CapitalHTGC
$139.7M-22.8%
Goldman Sachs BDC logo
Goldman Sachs BDCGSBD
$172.78M-18.1%
Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
$689.2M+407%
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$114K+14.0%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
-$473K
Seaboard logo
SeaboardSEB
-$5M+58.3%

Other financials

Income statement

See full
Net income-$18.9M+47.9%
EPS (diluted)-$0.21+50.0%

Balance sheet

See full
Cash & equivalents$51.3M-52.6%
Total debt$1.5B+2.3%
Total equity$1.4B-6.3%
Total assets$2.9B-6.0%

Cash flow

See full
Operating cash flow$130.7M+111%

Valuation

See full
Market cap$1B-16.8%
Enterprise value$2.43B-4.4%
P/E20.2×-113×

Returns & leverage

See full
Return on equity3.5%+2.9pp
Debt / equity1.1×+0.1×

Where this comes from

Reported directly by Oaktree Specialty Lending in its filing.

Tagged under the XBRL concept ocsl:InvestmentCompanyDistributableEarningsLossAccumulatedUnrealizedGainsLosses.

The official record: Oaktree Specialty Lending’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oaktree Specialty Lending's unrealized losses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oaktree Specialty Lending's unrealized losses, net?
Oaktree Specialty Lending (OCSL) reported unrealized losses, net of -$241.77M in Q3 2025.
What is the long-term trend for Oaktree Specialty Lending's unrealized losses, net?
Over 3 years (2022 to 2025), Oaktree Specialty Lending's unrealized losses, net has grown at a 16.4% compound annual growth rate (CAGR), from -$153.12M to -$241.77M.
What does unrealized losses, net mean?
Represents the net cumulative unrealized losses on the investment portfolio that have not yet been realized through a sale or exit event. This metric provides insight into the potential downward valuation pressure on the company's assets. It serves as a key indicator of portfolio quality and potential future impairment risks.